Imaging diagnosis-hypoglycemia associated with cholangiocarcinoma and peritoneal carcinomatosis in a horse.

The study discusses the case of an 8-year-old horse that exhibited symptoms such as decreased appetite, ataxia, and weakness, which upon investigation turned out to be due to cholangiocarcinoma, cancer of the bile duct, with extensive metastasis causing hypoglycemia.

Method of Diagnosis

The primary diagnostic methods used in this case were:

• Ultrasound: The abdominal ultrasound revealed a substantial amount of anechoic (in other words, ‘free from echo’) fluid along with multiple masses in the spleen, liver, and diaphragm.
• Radiography: Pleural fluid was discovered through the use of thoracic radiography and ultrasonography. Further radiographs identified pulmonary interstitial nodules, an uneven dorsal diaphragmatic margin, and enlarged tracheobronchial lymph nodes.
• Clinical Signs: The horse’s symptoms, which included weakness and minor seizures, occurred concurrent with hypoglycemic episodes.

Final Diagnosis

The final diagnosis in this case was that the horse was suffering from cholangiocarcinoma, a specific type of cancer affecting the bile duct. This had led to extensive metastasis, where cancerous cells spread to other parts of the body away from the initial location.

Observations and test findings allowed the veterinary doctors to link the symptoms presented by the horse – such as weakness, seizure, and ataxia (loss of full control of body movements) – to a paraneoplastic syndrome known as tumor-associated hypoglycemia. This condition, however, is not regularly reported in horses.

Significance of Study

The study brings attention to the potential of advanced diagnostic techniques in animals, which can detect complex conditions such as hypoglycemia-induced paraneoplastic syndrome due to cholangiocarcinoma, a finding that is not frequent in the equine community. It provides important information for veterinarians to consider when identifying and treating similar cases, contributing to better diagnostic and therapeutic strategies in the future.